ClinicalTrials.govpublic full text
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
her2-positive gastric cancer patients with liver metastasis, gastric cancer, neoadjuvant chemotherapy, capecitabine, oxaliplatin, lapatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891050
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.